Yoshihiro Muragaki

8PUBLICATIONS
18CO-AUTHORS
Reaction kinetics and dynamicsPredictive and prognostic markersGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 07, 2026
Carbenoxolone Modulates Dopamine D2 Receptor-Associated Inflammatory Responses After Ischemic Stress.

|Oct 29, 2025
Correction: Onodera et al. Prognostic Factors and Talaporfin Sodium Concentration in Photodynamic Therapy for Recurrent Grade 4 Glioma. Pharmaceuticals 2025, 18, 583.

Mikoto Onodera, Shuji Kitahara, Yasuto Sato

|Aug 07, 2025
Association between autologous formalin-fixed tumor vaccine (AFTV) therapy, molecular pathological markers, and survival outcomes in glioblastoma.

Shunichi Koriyama, Yoshihiro Muragaki, Masayuki Nitta

|Apr 26, 2025
Prognostic Factors and Talaporfin Sodium Concentration in Photodynamic Therapy for Recurrent Grade 4 Glioma.

Mikoto Onodera, Shuji Kitahara, Yasuto Sato

|Jan 24, 2025
Glioma Image-Level and Slide-Level Gene Predictor (GLISP) for Molecular Diagnosis and Predicting Genetic Events of Adult Diffuse Glioma.

Minh-Khang Le, Masataka Kawai, Kenta Masui

|Oct 04, 2021
Impact of awake mapping on overall survival and extent of resection in patients with adult diffuse gliomas within or near eloquent areas: a retrospective propensity score-matched analysis of awake craniotomy vs. general anesthesia.

Atsushi Fukui, Yoshihiro Muragaki, Taiichi Saito

Pageof 2

Frequent Collaborators

3 joint publications

Takakazu Kawamata

2 joint publications

Shuji Kitahara

2 joint publications

Yasuto Sato

1 joint publications

Minh-Khang Le